Results 181 to 190 of about 104,693 (298)

Utility of an alpha-1 adrenergic agonist in the management of chylothorax: a case series and management algorithm

Rubén Peralta, Ahmed Faidh Ramzee, Zeenat Khuda Bakhsh, Ayman El‐Menyar, A. Ajaj, Hassan Al‐Thani   +5 more
openalex   +2 more sources

Agonist-dependent phosphorylation of the alpha 2-adrenergic receptor by the beta-adrenergic receptor kinase.

, 1987
J.L. Benovic, John W. Regan, Hiroaki Matsui, Federico Mayor, Susanna Cotecchia, L.M. Fredrik Leeb-Lundberg, Marc G. Caron, Robert J. Lefkowitz   +7 more
openalex   +1 more source

Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists.

HYPERTENSION, 1984
J. Reid, B. Campbell, C. Hamilton
semanticscholar   +1 more source

Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management

Medicinal Research Reviews, Volume 46, Issue 1, Page 272-298, January 2026.
ABSTRACT Neurodegenerative disorders, including Alzheimer's disease (AD), impose a significant burden on society due to their progressive nature and the associated healthcare costs. Autophagy, a vital cellular degradation process, has emerged as a promising therapeutic target in these disorders.
Baljinder Singh, Shubham Mahajan, Sadikalmahdi Abdella, Rehan Khan, Sanjay Garg   +4 more
wiley   +1 more source

Aβ and tau clearance through aerobic exercise: unveiling the β2-adrenergic receptor's role in regulating autophagy-lysosomal pathways. [PDF]

Autophagy Rep
Yang L, Yu H, Chai GS.
europepmc   +1 more source

A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal☆

, 2008
Elmer Yu, Karen Miotto, Evaristo Akerele, Ann Elizabeth Montgomery, Ahmed Elkashef, Robert Walsh, Iván D. Montoya, Marian W. Fischman, Joseph Collins, Frances McSherry, Kathy D. Boardman, David K. Davies, Charles P. O’Brien, Walter Ling, Herbert D. Kleber, Barbara H. Herman   +15 more
openalex   +1 more source

The contribution of both extracellular and intracellular calcium to the action of alpha-adrenergic agonists in perfused rat liver.

Biochemical Journal, 1984
P. Reinhart, W. Taylor, F. L. Bygrave
semanticscholar   +1 more source

Haemodynamic Changes After Prophylactic Doses of Ephedrine, Phenylephrine, Norepinephrine Versus Placebo During Induction of General Anaesthesia: A Randomised Trial

Acta Anaesthesiologica Scandinavica, Volume 70, Issue 1, January 2026.
ABSTRACT Background Ephedrine, phenylephrine, and norepinephrine are commonly used to manage hypotension during the induction of anaesthesia. The objective of this study was to evaluate whether prophylactic administration of assumed equipotent doses of these vasopressors could maintain systolic arterial blood pressure (SAP) and heart rate (HR) within ...
Gunnar Helge Sjøen, Tor Hugo Hauge, Ragnhild Sørum Falk, Tor Inge Tønnessen, Eldrid Langesæter   +4 more
wiley   +1 more source

Immuno-oncological effects of the α2-adrenoceptor agonist dexmedetomidine. [PDF]

Oncoimmunology
Bezu L, Kepp O, Kroemer G.
europepmc   +1 more source

Regulation of adrenergic receptor function by phosphorylation. I. Agonist-promoted desensitization and phosphorylation of alpha 1-adrenergic receptors coupled to inositol phospholipid metabolism in DDT1 MF-2 smooth muscle cells.

, 1987
L.M. Fredrik Leeb-Lundberg, Susanna Cotecchia, Antonio DeBlasi, Marc G. Caron, Robert J. Lefkowitz   +4 more
openalex   +1 more source